Over the past year, cattle producers had the opportunity to harness the therapeutic potential of Pennchlor (chlortetracycline Type A medicated article), coupled with the coccidiosis control and performance enhancements offered by Rumensin (monensin Type A medicated article) in their starter rations. But now, two new supplemental claims are available for the well-established combination of Pennchlor and Rumensin. These additional claims now extend this combination’s therapeutic advantages for dairy and beef replacement heifers.
At a time when input costs, including feed, are above historic…